Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCAP.L Regulatory News (CCAP)

  • There is currently no data for CCAP

Interim Management Statement

12 Jul 2013 07:00

RNS Number : 1606J
Charlemagne Capital Limited
12 July 2013
 



12 July 2013

 

 

Interim Management Statement for the Six Months Ended 30 June 2013

 

 

Charlemagne Capital Limited ("Charlemagne" or the "Group") sets out below the key Revenue items and Assets under Management ("AuM") for the first six months of its current financial year.It is expected that the interim financial results will be announced on 17 September 2013.

 

Key highlights and Group AuM

 

§ As at 30 June 2013, Group AuM were US$2.4 billion, down by 8.1% since 1 January 2013;

 

§ Net management fees of US$11.9 million, up 10.2% on the previous six months;

 

·; The Group remains well-capitalised with a strong and liquid balance sheet; and

 

·; Strong relative performance in key investment strategies.

 

 

The table below sets out the Group's AuM as at 30 June 2013 and the movements experienced in each product range in the period since 1 January 2013.

 

01-Jan-13

Net Subscriptions

Net Performance

30-Jun-13

Movement In

AuM (US$m)

(US$m)

(%)

(US$m)

(%)

AuM (US$m)

Period (%)

Magna

364

86

23.6

(30)

(7.4)

420

15.4

OCCO

597

(36)

(6.0)

25

4.3

586

(1.8)

Institutional

1,526

(113)

(7.4)

(125)

(8.5)

1,288

(15.6)

Specialist

145

(17)

(11.7)

(4)

(2.9)

124

(14.5)

Total

2,632

(80)

(3.0)

(134)

(5.2)

2,418

(8.1)

 

Notes:

Closing AuM is stated as including all subscription and redemption orders received for the relevant funds as at the close of the period but not processed until the first dealing date of the following period.

 

Unaudited revenue numbers for the six months ended 30 June 2013

 

Net management fees receivable were US$11.9 million compared with US$10.8 million for the previous six months and US$9.7 million for the comparable period of 2012, reflecting the higher average AuM over the period of US$2.6 billion compared with US$2.4 billion in 2012 and a small increase in net margin arising from the greater proportion of OCCO higher fee classes that have been present for the full period. OCCO management fees, which are subject to a minority interest, account for nearly 44% of total net fee income during the period.

 

Crystallised performance fees were US$0.5 million compared with US$0.9 million for the comparative period in 2012. Accruing performance fees1 for 2013 which have not crystallised were US$5.9 million, principally from OCCO, compared with US$3.5 million as at the same date in 2012.

 

 

_________________________________________________________________________

1Performance fees accrue throughout the reporting period in the accounts of each relevant fund. It is the group's accounting policy only to recognise such revenues as they crystallise at the year-end date of the fund or, in certain cases, on redemption. Levels of accrued performance fees at any particular time should not be seen as necessarily indicative of the eventual crystallised figures, especially in periods of above average market volatility.

 

Dividend

 

In the absence of unforeseen circumstances, the Group intends to declare an interim dividend in respect of the six months to 30 June 2013. Further details will be provided in the interim results announcement planned for 17 September 2013.

 

Summary

 

Emerging markets have returned a negative performance over the period with the greatest falls in value occurring in June, when the MSCI Emerging markets index was down by 6.4% for the month resulting in a 9.6% ( in US$) drop over the full half year.

 

Over the period, the relative performance of Charlemagne's key equity strategies has been strong, with seven of the nine Magna sub-funds in the top half of their FactSet Morningstar peer group. Notably, theMagna Emerging Markets Dividend Fund, which has a full three year track record as of June 2013, has achieved first quartile performance over all periods since inception and has outperformed the MSCI EM index by 7.6% for the year to date with lower volatility than the index.

 

The positive net inflows into the Magna funds over the first half of the year are predominantly due to subscriptions into the Magna Emerging Markets Dividend Fund. The institutional business benefitted from the acquisition of a new US$45 million Eastern European mandate and US$60 million from existing mandates. However a partial asset reallocation from a long standing mandate, together with outflows from sub advisory business caused the overall net flows to be negative in this category. The OCCO Eastern European Fund also suffered net outflows as some investors reassessed their exposure to the asset class.

 

Outlook

 

In the last quarter of 2012, emerging markets began to outperform developed markets after a period of two years when they had lagged. Inflows returned to the asset class and the outlook was optimistic. The outperformance has reversed in 2013 as not only have emerging markets produced negative returns, but they have also again underperformed developed markets. Momentum has stalled as investors have reassessed asset allocations and industry flows have been negative. Despite strong relative performance our asset values have consequently fallen over the period. Although the Group remains profitable overall in the year to date, an increase in AuM is required in order to ensure sustainable profits on a recurring management fee basis. Under current circumstances, the generation of performance fees during the remainder of the year will be a significant factor in determining full year profit levels. We are reviewing the cost base but are committed to preserving the necessary infrastructure required to service our investors and for future expansion.

 

We believe that, although markets will remain volatile now that the issue of reduced Central Bank support to liquidity is out in the open, there are still reasons for a positive outlook. Equity markets have overreacted and have quickly over discounted a worst possible outcome. Deflationary forces are still such that meaningful interest rate hikes are a long way off and valuations are sufficiently below average to suggest returns from such levels should typically be strong over subsequent 12-18 month periods.

 

 

Enquiries:

 

Charlemagne Capital

 

Jayne Sutcliffe, Chief Executive

Tel. 020 7518 2100

Lloyd Jones, Finance Director

Tel. 01624 640200

 

 

N+1 Singer

+44 020 7496 3000

Jonny Franklin-Adams

Nick Donovan

 

 

 

Smithfield Consultants

Tel. 020 7360 4900

John Kiely

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKMGMNKMLGFZM
Date   Source Headline
15th Sep 20082:33 pmRNSDirector/PDMR Shareholding
15th Sep 200810:25 amRNSHolding(s) in Company
11th Sep 20087:00 amRNSTransaction in Own Shares
8th Sep 20087:00 amRNSTransaction in Own Shares
5th Sep 20087:00 amRNSTransaction in Own Shares
4th Sep 20081:49 pmRNSViewing Interim Financial Sta
3rd Sep 20087:01 amRNSDividend Declaration
3rd Sep 20087:00 amRNSInterim Results
14th Aug 20087:00 amRNSNotice of Results
13th Aug 20087:00 amRNSDividend Election Procedure
11th Jul 20087:00 amRNSHalf Year Trading Statement
18th Jun 20087:00 amRNSAnnual Report and Interim Res
27th May 20087:00 amRNSLaunch of New Fund
7th May 200812:32 pmRNSResult of AGM
7th May 20089:13 amRNSAGM Statement
15th Apr 20089:20 amRNSDirector/PDMR Shareholding
15th Apr 20087:00 amRNSDirector/PDMR Shareholding
11th Apr 200811:19 amRNSDirector/PDMR Shareholding
9th Apr 20087:00 amRNSStatement re Q1 AuM Update
28th Mar 200810:03 amRNSDirector/PDMR Shareholding
19th Mar 20081:38 pmRNSDirector/PDMR Shareholding
6th Mar 20083:39 pmRNSHolding(s) in Company
4th Mar 20085:38 pmRNSTransaction in Own Shares
27th Feb 20084:38 pmRNSDirectorate Change
27th Feb 20084:34 pmRNSHolding(s) in Company
27th Feb 20087:01 amRNSDividend Declaration
27th Feb 20087:01 amRNSFinal Results
15th Feb 20085:22 pmRNSHolding(s) in Company
7th Feb 20085:02 pmRNSHolding(s) in Company
7th Feb 200812:25 pmRNSHolding(s) in Company
31st Jan 20085:37 pmRNSHolding(s) in Company
25th Jan 20087:00 amRNSNotice of Final Results
15th Jan 20083:08 pmRNSHolding(s) in Company
10th Jan 20087:00 amRNSTrading Statement
9th Jan 20087:00 amBUSHolding(s) in Company
2nd Jan 20084:42 pmRNSHolding(s) in Company
10th Dec 20079:23 amRNSDirector/PDMR Shareholding
10th Dec 20079:19 amRNSHolding(s) in Company
30th Nov 20077:35 amRNSTransaction in Own Shares
21st Nov 20075:48 pmRNSTransaction in Own Shares
19th Nov 20075:37 pmRNSTransaction in Own Shares
16th Nov 20075:36 pmRNSTransaction in Own Shares
14th Nov 20077:01 amRNSE. European OCCO Fund Closes
6th Nov 20075:24 pmRNSTransaction in Own Shares
17th Oct 20077:00 amRNSTransaction in Own Shares
15th Oct 20077:01 amRNSTransaction in Own Shares
4th Oct 20077:01 amRNSAssets under Manage
4th Oct 20077:01 amRNSTransaction in Own Shares
19th Sep 20075:58 pmRNSTransaction in Own Shares
17th Sep 20075:15 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.